Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 22, 2012
NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc., announced that the Company has signed a manufacturing agreement with Florida Biologix for the production of the sterile liquid form of its Trappsol Cyclo product, an orphan ...
read more
CGT Catapult’s cell and gene therapy manufacturing center has been officially opened by the Business Secretary Greg Clark and Science Minister Sam Gyimah.
read more
CURE Pharmaceutical has named Dr. Vered Gigi, Vice President of Strategy and Business Development.
read more
CURE Pharmaceutical has closed on the previously announced acquisition of Chemistry Holdings, a formulation technology company that is develops delivery systems for a variety of industries.
read more
Monday, December 02, 2019
CureVac has received manufacturing authorization for clinical trial materials produced under GMP from Regierungspräsidium Tübingen for the company’s scaled up GMP III production suite.
read more
Friday, December 04, 2020
CureVac and Wacker Chemie have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility. The increased capability to flexibly manufacture ...
read more
Tuesday, January 04, 2022
Curia, formerly AMRI, has unveiled its messenger RNA (mRNA) solution, which includes discovery, process development and mRNA drug substance production, through large-scale lipid manufacturing, lipid nanoparticle (LNP) formulation and development for ...
read more
A California dietary supplement manufacturer recently was ordered by a federal court to stop selling its products until the company comes into compliance with the FDA’s dietary supplement manufacturing regulations and other requirements listed in a ...
read more
Wednesday, March 30, 2022
CVS Health has entered into an agreement with the State of Florida to resolve claims dating back more than a decade related to prescriptions for opioid medications that were filled at Florida CVS Pharmacy locations.
read more
CyanVac announced they have selected Exothera for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector.
read more
Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a ...
read more
Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development.
read more
Thursday, September 08, 2022
Cytel expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions.
read more